Nuwellis, Inc. (NASDAQ:NUWE) shares are trading higher Monday after the company announced Friday that the first pediatric patient has been treated with the newly launched Quelimmune therapy in a ...

Nuwellis Inc (NASDAQ:NUWE) successfully resolved a temporary backorder issue with their sterilization vendor, which had impacted revenue. The pediatrics business segment showed strong performance with ...

Nuwellis (NUWE) stock analysis \| earnings growth and investor sentiment remain in focus. Nuwellis Inc. (NUWE) closed at ...

John Erb, Current Chair of the Board, Appointed Interim President and CEOMINNEAPOLIS, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on ...

The price trend for Nuwellis, Inc. (NUWE) has been bearish lately and the stock has lost 18.7% over the past week. However, the formation of a hammer chart pattern in its last trading session ...

The FDA is addressing a potentially high-risk issue linked to certain lots of the AquaFlexFlow UF 500 Plus extracorporeal blood circuit, a device produced by Nuwellis Inc (NASDAQ:NUWE). The device, ...

Nuwellis ( (NUWE)) has provided an announcement. Nuwellis disclosed limited information in a brief regulatory-related statement, indicating that certain details are being reported in connection with ...

Nuwellis Inc (NASDAQ:NUWE) reported a 23% increase in consumables utilization and a fourfold increase in US console sales sequentially from the second quarter. The company introduced a new 24-hour ...